000 | 00986 a2200277 4500 | ||
---|---|---|---|
005 | 20250518041351.0 | ||
008 | ####s 0 0 eng d | ||
022 | _a1734-1922 | ||
024 | 7 |
_a10.5114/aoms.2018.76141 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLi, Kun-Peng | |
245 | 0 | 0 |
_aFull dose, half dose, or discontinuation of etanercept biosimilar in early axial spondyloarthritis patients: a real-world study in China. _h[electronic resource] |
260 |
_bArchives of medical science : AMS _cMay 2019 |
||
300 |
_a700-705 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
700 | 1 | _aJin, Jing-Yu | |
700 | 1 | _aYang, Jin-Shui | |
700 | 1 | _aLi, Yan | |
700 | 1 | _aZhao, Wei | |
700 | 1 | _aLuo, Gui | |
700 | 1 | _aZhu, Jian | |
700 | 1 | _aZhang, Jiang-Lin | |
700 | 1 | _aHuang, Feng | |
773 | 0 |
_tArchives of medical science : AMS _gvol. 15 _gno. 3 _gp. 700-705 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.5114/aoms.2018.76141 _zAvailable from publisher's website |
999 |
_c29711661 _d29711661 |